Induction of vascular endothelial growth factor and matrix metalloproteinase-3 (stromelysin) by interleukin-1 in human articular chondrocytes and synoviocytes

Rheumatology International

Volumn 26, Issue 2, 2005, Pages 93-98

  Inoue, Kenji ^a   Masuko Hongo, Kayo ^a   Okamoto, Masahiro ^a   Nishioka, Kusuki ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chondrocytes; Interleukin 1; Interleukin 1 receptor antagonist; Matrix metalloproteinase 3; Vascular endothelial growth factor

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MESSENGER RNA; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; STROMELYSIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CARTILAGE CELL; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MEASUREMENT; OSTEOARTHRITIS; PATHOGENESIS; POSTTRAUMATIC ARTHROPATHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; UPREGULATION;

AGED; AGED, 80 AND OVER; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; DRUG COMBINATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; RECEPTORS, INTERLEUKIN-1; RECOMBINANT PROTEINS; RNA, MESSENGER; SIALOGLYCOPROTEINS; SYNOVIAL MEMBRANE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 28844456520     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-004-0513-6     Document Type: Article

References (14)

1. Thomas K (1996) Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 271:603-606
2. Gerber H, Vu T, Ryan A, Kowalski J, Werb Z, Ferrara N (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5:623-628
3. Pfander D, Kortje D, Zimmermann R, Weseloh G, Kirsch T, Gesslein M, Cramer T, Swoboda B (2001) Vascular endothelial growth factor in articular cartilage in healthy and osteoarthritic human knee joints. Ann Rheum Dis 60:1070-1073
4. Pufe T, Petersen W, Tillmann B, Mentlein R (2001) The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum 44:1082-1088
5. Hashimoto S, Creighton-Achermann L, Takahashi K, Amiel D, Coutts R, Lotz M (2002) Development and regulation of osteophyte formation during experimental osteoarthritis. Osteoarthritis Cart 10:180-187
6. van den Berg W (2001) Anti-cytokine therapy in chronic destructive arthritis. Arthritis Res 3:18-26
7. Granowitz E, Clark B, Mancilla J, Dinarello C (1991) Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J Biol Chem 266:14147-14150
8. Mueller-Ladner U, Roberts C, Franklin B, Gay R, Robbins P, Evans C, Gay S (1997) Human IL-1ra gene transfer into human synovial fibroblasts is chondroprotective. J Immunol 158:3492-3498
9. Fernandes J, Tardif G, Martel-Pelletier J, Lascau-Coman V, Dupuis M, Moldovan F, Sheppard M, Krishnan B, Pelletier J (1999) In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression. Am J Pathol 154:1159-1169
10. Salven P, Hattori K, Heissig B, Rafii S (2002) Interleukin-1a (IL-1a) promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB J 16:1471-1473
11. Bresnihan B (2002) Effects of anakinra on clinical and radiological outcomes in rheumatoid arthritis. Ann Rheum Dis 61 [Suppl 2]:ii74-ii77
12. Enomoto H, Inoki I, Komiya K, Shiomi T, Ikeda E, Obata K, Matsumoto H, Toyama Y, Okada Y (2003) Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritis cartilage. Am J Pathol 162:171-181
13. Turpaev K, Litvinov D, Dubovaya V, Panasyuk A, Ivanov D, Prassolov V (2001) Induction of vascular endothelial growth factor by nitric oxide in cultured human articular chondrocytes. Biochimie 83:515-522
14. Jiang Y, Genant H, Watt I, Cobby M, Bresnihan B, Aitchison R, McCabe D (2000) A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 43:1001-1009